Terms: = Prostate cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1 AND Diagnosis
13 results:
1. Prostatic ductal adenocarcinoma variant predicts worse pathological and oncological outcomes: Insight from over 1000 consecutive patients from a large prospective uro-oncology registry.
Tan YG; Khalid F; Huang HH; Chen K; Tay KJ; Lau WKO; Cheng CWS; Ngo NT; Yuen JSP
Prostate; 2021 Mar; 81(4):242-251. PubMed ID: 33428259
[TBL] [Abstract] [Full Text] [Related]
2. Feasibility and performance of a novel probe panel to detect somatic DNA copy number alterations in clinical specimens for predicting prostate cancer progression.
Liu W; Hou J; Petkewicz J; Na R; Wang CH; Sun J; Gallagher J; Bogachkov YY; Swenson L; Regner M; Resurreccion WK; Isaacs WB; Brendler CB; Crawford S; Zheng SL; Helfand BT; Xu J
Prostate; 2020 Oct; 80(14):1253-1262. PubMed ID: 32803894
[TBL] [Abstract] [Full Text] [Related]
3. Co-occurrence of multiple endocrine neoplasia type 4 and spinal neurofibromatosis: a case report.
Brock P; Bustamante Alvarez J; Mortazavi A; Roychowdhury S; Phay J; Khawaja RA; Shah MH; Konda B
Fam Cancer; 2020 Apr; 19(2):189-192. PubMed ID: 32052251
[TBL] [Abstract] [Full Text] [Related]
4. Uptake of Active Surveillance for Very-Low-Risk prostate cancer in Sweden.
Loeb S; Folkvaljon Y; Curnyn C; Robinson D; Bratt O; Stattin P
JAMA Oncol; 2017 Oct; 3(10):1393-1398. PubMed ID: 27768168
[TBL] [Abstract] [Full Text] [Related]
5. miR-24 regulates cdkn1b/p27 expression in prostate cancer.
Lynch SM; McKenna MM; Walsh CP; McKenna DJ
Prostate; 2016 May; 76(7):637-48. PubMed ID: 26847530
[TBL] [Abstract] [Full Text] [Related]
6. Replication study of 34 common SNPs associated with prostate cancer in the Romanian population.
Jinga V; Csiki IE; Manolescu A; Iordache P; Mates IN; Radavoi D; Rascu S; Badescu D; Badea P; Mates D
J Cell Mol Med; 2016 Apr; 20(4):594-600. PubMed ID: 26773531
[TBL] [Abstract] [Full Text] [Related]
7. The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells.
Pernicová Z; Slabáková E; Fedr R; Šimečková Š; Jaroš J; Suchánková T; Bouchal J; Kharaishvili G; Král M; Kozubík A; Souček K
Mol Cancer; 2014 May; 13():113. PubMed ID: 24884804
[TBL] [Abstract] [Full Text] [Related]
8. Altered expression of Akt signaling pathway parameters in prostate needle biopsies derived from benign, adjacent and cancerous tissue.
Waalkes S; Simon P; Hennenlotter J; Knapp J; Tezval H; Serth J; Stenzl A; Kuczyk MA; Merseburger AS
Oncol Rep; 2010 May; 23(5):1257-60. PubMed ID: 20372838
[TBL] [Abstract] [Full Text] [Related]
9. A molecularly genetic determination of prognostic factors of the prostate cancer and their relationships to expression of protein p27kip1.
Dvorácková J; Uvírová M
Neoplasma; 2007; 54(2):149-54. PubMed ID: 17319789
[TBL] [Abstract] [Full Text] [Related]
10. Apoptotic regulators in prostatic intraepithelial neoplasia (PIN): value in prostate cancer detection and prevention.
Zeng L; Kyprianou N
Prostate Cancer Prostatic Dis; 2005; 8(1):7-13. PubMed ID: 15477876
[TBL] [Abstract] [Full Text] [Related]
11. A polymorphism in the cdkn1b gene is associated with increased risk of hereditary prostate cancer.
Chang BL; Zheng SL; Isaacs SD; Wiley KE; Turner A; Li G; Walsh PC; Meyers DA; Isaacs WB; Xu J
Cancer Res; 2004 Mar; 64(6):1997-9. PubMed ID: 15026335
[TBL] [Abstract] [Full Text] [Related]
12. CDKN1A and cdkn1b polymorphisms and risk of advanced prostate carcinoma.
Kibel AS; Suarez BK; Belani J; Oh J; Webster R; Brophy-Ebbers M; Guo C; Catalona WJ; Picus J; Goodfellow PJ
Cancer Res; 2003 May; 63(9):2033-6. PubMed ID: 12727815
[TBL] [Abstract] [Full Text] [Related]
13. Relational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model.
Manley S; Mucci NR; De Marzo AM; Rubin MA
Am J Pathol; 2001 Sep; 159(3):837-43. PubMed ID: 11549576
[TBL] [Abstract] [Full Text] [Related]